Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,950 JPY | -0.19% | -1.52% | -20.48% |
12/04 | Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months | MT |
12/04 | COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.48% | 319.64Cr | |
-28.47% | 276.92Cr | |
+2.24% | 249.05Cr | |
-20.15% | 192.07Cr | |
-4.55% | 178.76Cr | |
+16.64% | 144.76Cr | |
-29.47% | 85Cr | |
-51.84% | 55Cr | |
-0.53% | 42Cr | |
+10.40% | 41Cr |
- Stock Market
- Equities
- 3349 Stock
- News COSMOS Pharmaceutical Corporation
- UBS Adjusts Cosmos Pharmaceutical's Price Target to 16,500 Yen From 17,500 Yen, Keeps at Neutral